| Symbol | EIKN |
|---|---|
| Name | EIKON THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 230 HARRIET TUBMAN WAY, MILLBRAE, California, 94030, United States |
| Telephone | +1 341 777-0566 |
| Fax | — |
| — | |
| Website | https://www.eikontx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001861123 |
| Description | We are data scientists and chemists, biologists and engineers, clinicians and lab managers, pharmacologists and software developers. We work across functions and employ diverse scientific languages. We work with super-resolution microscopes, living cells, algorithms, and robotics - all so we can observe therapeutically relevant biology in a way no one has before. We are endlessly curious, intellectually honest and we love what we do. We are driven to explore mechanisms of biology and pharmacology at the molecular level, and to make the biggest difference in as many lives as possible. Additional info from NASDAQ: |
(30% Negative) EIKON THERAPEUTICS, INC. (EIKN) Reports Q1 2026 Financial Results
Read moreEikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Read moreNew Form 10-K - Eikon Therapeutics, Inc. <b>Filed:</b> 2026-03-30 <b>AccNo:</b> 0001193125-26-130395 <b>Size:</b> 53 MB
Read more